# Cell Lines Used for 96 files in This Study / 本研究使用的细胞系

| Cell line | 来源 (Origin) | 特点 (Key Features) | 应用 (Applications) |
|-----------|--------------|---------------------|---------------------|
| **293T** | 人胚胎肾细胞，经 SV40 T-antigen 转染 (Human embryonic kidney, SV40 T-antigen) | 转染效率极高 (Very high transfection efficiency) | 蛋白表达、病毒包装 (Protein expression, viral packaging) |
| **RPE1** | 人视网膜色素上皮细胞，hTERT 永生化 (Retinal pigment epithelial, hTERT immortalized) | 近二倍体，非癌 (Near-diploid, non-cancerous) | 细胞周期、DNA 修复研究 (Cell cycle, DNA repair studies) |
| **U2OS** | 人骨肉瘤 (Human osteosarcoma) | p53 野生型，端粒 ALT 机制 (p53 WT, ALT telomere mechanism) | 端粒研究、细胞周期 (Telomere biology, cell cycle) |
| **HeLa** | 宫颈癌 (Cervical cancer) | 增殖力强，最经典细胞系 (Highly proliferative, most widely used cell line) | 广泛用于生物医学研究 (Widely used in biomedical research) |
| **MCF7** | 乳腺癌 (Breast cancer, ER+) | 雌激素受体阳性，对激素敏感 (ER+, hormone responsive) | 乳腺癌机制与内分泌治疗 (Breast cancer and endocrine therapy) |
| **HCT116** | 结直肠癌 (Colorectal cancer) | 可得 p53+/+ 与 p53-/- 对照株 (Available in p53+/+ and -/-) | 癌症代谢、DNA 修复研究 (Cancer metabolism, DNA repair) |
| **Panc1** | 胰腺癌 (Pancreatic ductal adenocarcinoma) | KRAS 突变，侵袭性高 (KRAS mutation, highly invasive) | 胰腺癌研究、耐药机制 (Pancreatic cancer, drug resistance) |
| **RKO** | 结肠癌 (Colon cancer) | p53 野生型，微卫星不稳定性 MSI+ (p53 WT, MSI+) | DNA 修复、免疫逃逸机制 (DNA repair, immune evasion) |

---

**Summary / 总结**  
这 8 个细胞系覆盖了多种代表性癌种（骨肉瘤、宫颈癌、乳腺癌、结直肠癌、胰腺癌）以及“正常”对照系 (RPE1)，为比较不同组织和基因型背景下的蛋白质组学差异提供了全面模型。

---
# Cell Lines Used for shaoxian's sample in This Study
| **HeLa** | 宫颈癌 (Cervical cancer) | 增殖力强，最经典细胞系 (Highly proliferative, most widely used cell line) | 广泛用于生物医学研究 (Widely used in biomedical research) |
